EHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Encompass Health Corp (EHC) does not currently present a strong buying opportunity for a beginner, long-term investor with $50,000-$100,000 available for investment. The technical indicators are bearish, and there are no significant positive catalysts or proprietary trading signals to suggest immediate upside potential. While analysts maintain a positive long-term outlook with buy ratings and price targets above the current price, the lack of recent news, weak technicals, and neutral trading sentiment suggest waiting for a more favorable entry point.
The technical indicators for EHC are bearish. The MACD is negatively expanding (-0.556), the RSI is neutral at 30.905, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 100.949, with key support at 97.578 and resistance at 104.32.
Analysts have a positive long-term outlook, citing Encompass Health's growth strategy in the under-supplied inpatient rehab industry. Price targets range from $125 to $150, significantly above the current price.
Technical indicators are bearish, and there is no recent news to act as a positive catalyst. Hedge funds and insiders are neutral, and there are no significant trading trends. Additionally, the stock trend analysis suggests a slight chance of negative movement in the short term.
No financial performance data available for the latest quarter.
Analysts maintain buy ratings with price targets ranging from $125 to $150. However, some firms have lowered their price targets recently, reflecting cautious optimism due to high occupancy rates and lower peer group multiples.
